Skip to Content

Tauriga Sciences Inc TAUG

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TAUG is trading at a 51% discount.
Price
$0.00
Fair Value
$9.54
Uncertainty
Extreme
1-Star Price
$1.99
5-Star Price
Economic Moat
Zxbsg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TAUG is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$299.91
Volume/Avg
6,334 / 25,934

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Tauriga Sciences Inc is a revenue-generating company that operates through the development, distribution, and licensing of proprietary products as well as evaluation of potential acquisition opportunities. The firm has entered into the cannabidiol (or CBD) infused chewing gum product business. This CBD-infused chewing gum product has been branded under Tauri-Gum. The company commenced sales of Peach-Lemon and Black Currant CBG Gum. It operates in two segments: Tauri-gum division consists of all retail, wholesale, and e-commerce product sales of CBD/CBG Tauri-Gum, Tauri-Gummies, and other CBD/CBG products. Pharma segment includes research and development of the company's FDA IND application for Phase II Trial of its proposed pharmaceutical-grade version of Tauri-Gum.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
2

Valuation

Metric
TAUG
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
TAUG

Financial Strength

Metric
TAUG
Quick Ratio
0.46
Current Ratio
0.68
Interest Coverage
−4.50
Quick Ratio
TAUG

Profitability

Metric
TAUG
Return on Assets (Normalized)
−213.64%
Return on Equity (Normalized)
−882.86%
Return on Invested Capital (Normalized)
−227.99%
Return on Assets
TAUG
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRLlwlstqhxQdnbsh$70.5 Bil
ZTS
Zoetis Inc Class ACcxbqqnmFczvj$69.4 Bil
HLN
Haleon PLC ADRLxxvftvcqSqh$36.6 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRRsmptbxDbbk$14.9 Bil
VTRS
Viatris IncCzkzzzzdlZrdq$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRQhsvwlvNzc$12.0 Bil
CTLT
Catalent IncNzrbqjylQbsqtl$10.1 Bil
PRGO
Perrigo Co PLCXrbczmrHhf$4.1 Bil
CURLF
Curaleaf Holdings IncVxwhpgrkYxp$3.7 Bil
PBH
Prestige Consumer Healthcare IncLpbbzxkqYdzkjb$3.4 Bil

Sponsor Center